CLINICAL_TRIALS
trial_result
· 2018-03-02
Clinical Trial Update: Effect of Increlex® on Children With Crohn Disease [Phase 2, Phase 3]
Summary
A Phase 2/3 trial of Increlex (mecasermin) in children with Crohn disease was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nationwide Children's Hospital | Conditions: Crohn Disease | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2018-03-02